Insmed (INSM) Interest Expenses (2011 - 2026)

Insmed has reported Interest Expenses for 16 years, with the latest figure at $20.3 million in Q2 2026.

• On a quarterly basis, Interest Expenses fell 4.58% year-over-year to $20.3 million in Q2 2026; TTM through Jun 2026 was $81.3 million, a 4.78% decrease from a year earlier, with the FY2025 full-year figure at $83.8 million, down 1.32% from the prior year.
• Interest Expenses was $20.3 million for Q2 2026 at Insmed, up from $20.1 million in the prior quarter.
• The five-year high for Interest Expenses was $21.6 million in Q1 2025, with the low at $3.3 million in Q1 2022.
• Average Interest Expenses over 5 years is $17.6 million, with a median of $20.5 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Interest Expenses sank 70.18% in 2022, then surged 514.21% in 2023.
• Over 5 years, Interest Expenses stood at $16.4 million in 2022, then grew by 26.38% to $20.8 million in 2023, then rose by 3.69% to $21.6 million in 2024, then fell by 4.41% to $20.6 million in 2025, then dropped by 1.58% to $20.3 million in 2026.
• The last three Interest Expenses figures came in at $20.3 million (Q2 2026), $20.1 million (Q1 2026), and $20.6 million (Q4 2025), per Business Quant data.